NCT04348786View on ClinicalTrials.gov

Comparing Efficacy of 14-day Therapy Doxycycline With Bismuth Subsalicylate Versus Levofloxacin With Tinadizole on Treatment Helicobacter Pylori

PHASE4CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

February 1, 2019

Primary Completion Date

August 30, 2020

Study Completion Date

September 1, 2020

Conditions
Helicobacter Pylori Infection
Interventions
DRUG

Doxycycline

Doxycylcine 100 mg bid ,esomprazole 20 bid,Bismuth subsalicylate 262 tab.2 tab q.i.d,Tinadizole 500 bid

DRUG

Levofloxacin 500mg

Levofloxacin 500 mg qd, amoxicillin 500 2cab bid,Tinadizole 500 bid, esomprazole 20 bid

Trial Locations (1)

Unknown

General Assembly of Damascus Hospital, Damascus

All Listed Sponsors
lead

Damascus Hospital

OTHER

NCT04348786 - Comparing Efficacy of 14-day Therapy Doxycycline With Bismuth Subsalicylate Versus Levofloxacin With Tinadizole on Treatment Helicobacter Pylori | Biotech Hunter | Biotech Hunter